Oxybutynin for the Treatment of Primary Hyperhidrosis: Current State of the Art | Zendy

Anna Campanati | Zendy; Stamatios Gregoriou | Zendy; George Kontochristopoulos | Zendy; Annamaria Offidani | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Oxybutynin for the Treatment of Primary Hyperhidrosis: Current State of the Art

Author(s) -

Anna Campanati,

Stamatios Gregoriou,

George Kontochristopoulos,

Annamaria Offidani

Publication year - 2015

Publication title -

skin appendage disorders

Language(s) - English

Resource type - Journals

eISSN - 2296-9195

pISSN - 2296-9160

DOI - 10.1159/000371581

Subject(s) - oxybutynin , hyperhidrosis , tolerability , anticholinergic , adverse effect , medicine , dry mouth , anesthesia , dermatology , intensive care medicine , alternative medicine , overactive bladder , pathology , saliva

Oxybutynin is an anticholinergic drug with an emerging role in the treatment of hyperhidrosis. Several recent studies have documented that it is effective both in focal and generalized hyperhidrosis and shows universally good response among different groups of patients regardless of age, gender, and weight. The most common adverse event is dry mouth reported by almost all patients treated. The way this might affect long-term compliance and tolerability should be better investigated in the future.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research